Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tuvalu Health Digest.
Press releases published on September 8, 2025
Unboxing Freshness: Chopped Leaf Catering Makes Serving Healthy Food Easier Than Ever
GlobeNewswire
·
September 8, 2025
Oakville, Ontario, Canada, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Chopped Leaf is unveiling a fresh take on catering this September with new portable catering boxes that make it easier than ever to serve healthy, feel-good meals for any occasion. Designed for …
Prenetics’ IM8 Congratulates Global Ambassador and Shareholder - World No. 1 Aryna Sabalenka on Defending Her US Open Championship
GlobeNewswire
·
September 8, 2025
Aryna Sabalenka becomes first woman to defend US Open title in more than a decade AI-powered Aryna Sabalenka ad goes viral with 233M Instagram views and Times Square billboard during US Open IM8 achieves 300,000+ customer purchases and 6 million servings …
First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity
GlobeNewswire
·
September 8, 2025
PD-L1xVEGF-A bispecific antibody pumitamig (BNT327/BMS986545) plus chemotherapy continues to show encouraging antitumor activity in patients with extensive-stage small cell lung cancer (”ES-SCLC”), expanding evidence for its potential to set a new standard …
Erste Zwischenergebnisse aus BioNTechs und BMS‘ globaler Phase-2-Studie mit bispezifischem PD-L1xVEGF-A-Antikörperkandidat Pumitamig (BNT327/BMS986545) zeigen ermutigende Anti-Tumor-Aktivität bei fortgeschrittenem kleinzelligem Lungenkrebs
GlobeNewswire
·
September 8, 2025
Daten zur Kombination des bispezifischen PD-L1xVEGF-A-Antikörper-Kandidaten Pumitamig (BNT327/BMS986545) mit Chemotherapie zeigen weiterhin ermutigende Anti-Tumor-Aktivitäten bei Patientinnen und Patienten mit kleinzelligem Lungenkrebs im fortgeschrittenen …
KFSHRC Launches Middle East’s First Smart Neuroscience Ward With Electromagnetic Shielding for Ultra-Precise Brain Monitoring
GlobeNewswire
·
September 8, 2025
RIYADH, Saudi Arabia, Sept. 08, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …
Vita Coco Unveils the “Concrete Jungle Gym” Experience in Brooklyn, Empowering Attendees to Break a Sweat and Recharge with Coconut Water, The Better Fitness Fuel™
GlobeNewswire
·
September 8, 2025
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Vita Coco (NASDAQ:COCO), America’s leading coconut water brand, announced today that it will bring the Concrete Jungle Gym, an immersive pop-up fitness experience, to Domino Square in Brooklyn from September …
Streamex Exchange Corp NASDAQ-BSGM Creates a Tokenized Yield-Bearing Gold Product Generating up-to 4% through Exclusive Partnership with Monetary Metals
GlobeNewswire
·
September 8, 2025
Partnership unlocks exclusive tokenization rights, a four percent (4%) annual yield target on physical bullion, revenue share tied to leasing volumes and the creation of a groundbreaking institutionalized asset providing yield on physical gold holdings Key …
Novatio Solutions Strengthens European Presence with New Office in Germany
GlobeNewswire
·
September 8, 2025
MANNHEIM, Germany, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Novatio Solutions, a niche consulting and implementation partner specializing in Supply Chain Transformation and AI, has officially expanded its global footprint with the opening of its new office in …
BlueGenesLab Expands Genetic Panel to Include Three New GLP-1–Related Genes
GlobeNewswire
·
September 8, 2025
SCOTTSDALE, Ariz., Sept. 08, 2025 (GLOBE NEWSWIRE) -- BlueGenesLab, a precision genomics company headquartered in Scottsdale, Arizona, today announced the addition of three genes to its clinical testing panel that influence GLP‑1 (glucagon‑like peptide‑1) …
Tevogen Values TVGN-489 at $9–$11 Billion rNPV, Its First Clinical Product From the Proprietary ExacTcell™ Allogeneic T Cell Platform
GlobeNewswire
·
September 8, 2025
WARREN, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today shared the risk-adjusted net present value (rNPV) estimate of $9 billion to $11 billion for TVGN-489, an allogeneic precision T cell …
New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM
GlobeNewswire
·
September 8, 2025
PRINCETON, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced the presentation of new 4-year muscle function, muscle strength and biomarker endpoints from the PROPEL open-label extension (OLE) study of …
MediciNova Provides Shareholder Update on Key Developments
GlobeNewswire
·
September 8, 2025
LA JOLLA, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), provides a …
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
GlobeNewswire
·
September 8, 2025
ATLANTA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced it has received approval from …
New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions
GlobeNewswire
·
September 8, 2025
SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, released results from a real-world analysis that showed 63% of Omada members maintained or continued to lose weight 12 months …
Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Programme
GlobeNewswire
·
September 8, 2025
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking …
Pelthos Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
September 8, 2025
DURHAM, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company (“Pelthos” or the “Company”) committed to commercializing innovative therapeutic products for high unmet patient needs, today …
Cannabix Technologies to Exhibit at National Safety Council (NSC) Safety Congress and Expo, Denver Colorado
GlobeNewswire
·
September 8, 2025
VANCOUVER, British Columbia, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report its …
Lexicon Pharmaceuticals Announces Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes
GlobeNewswire
·
September 8, 2025
Data obtained from ongoing third-party funded, investigator-sponsored trials have been submitted in effort to address the December 2024 complete response letter Company seeks alignment on reasonable path forward for Zynquista NDA resubmission FDA feedback …
Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia
GlobeNewswire
·
September 8, 2025
Spain site opens with two R/R AML subjects enrolled; One treated On track to recruit 45 subjects in 4Q25 for initial data unblinding HOUSTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late- …
Vivos Inc. Demonstrates Precision in Precision Radionuclide Therapy
GlobeNewswire
·
September 8, 2025
Kennewick, WA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) announced new data demonstrating the exceptional precision of its proprietary Precision Radionuclide Therapy (RadioGel® for human therapies and IsoPet® for veterinary applications) …